Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT).

Saved in:
Bibliographic Details
Title: Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT).
Authors: Jolliffe DA; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK., Holt H; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.; Asthma UK Centre for Applied Research, Queen Mary University of London, London, UK., Greenig M; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK., Talaei M; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK., Perdek N; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK., Pfeffer P; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK., Vivaldi G; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK., Maltby S; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK., Symons J; Jane Symons Media, London, UK., Barlow NL; Clinical Biochemistry Department, Black Country Pathology Services, City Hospital, Birmingham, UK., Normandale A; Clinical Biochemistry Department, Black Country Pathology Services, City Hospital, Birmingham, UK., Garcha R; Clinical Biochemistry Department, Black Country Pathology Services, City Hospital, Birmingham, UK., Richter AG; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Faustini SE; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Orton C; Population Data Science, Swansea University Medical School, Swansea, UK.; Health Data Research UK BREATHE Hub, Swansea University, Swansea, UK., Ford D; Population Data Science, Swansea University Medical School, Swansea, UK.; Health Data Research UK BREATHE Hub, Swansea University, Swansea, UK., Lyons RA; Population Data Science, Swansea University Medical School, Swansea, UK.; Health Data Research UK BREATHE Hub, Swansea University, Swansea, UK., Davies GA; Population Data Science, Swansea University Medical School, Swansea, UK.; Health Data Research UK BREATHE Hub, Swansea University, Swansea, UK.; Asthma UK Centre for Applied Research, University of Edinburgh, Edinburgh, UK., Kee F; Centre for Public Health (NI), Queen's University Belfast, Belfast, UK., Griffiths CJ; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.; Asthma UK Centre for Applied Research, Queen Mary University of London, London, UK.; Health Data Research UK BREATHE Hub, Queen Mary University of London, London, UK., Norrie J; Usher Institute, University of Edinburgh, Edinburgh, UK.; Health Data Research UK BREATHE Hub, University of Edinburgh, Edinburgh, UK., Sheikh A; Asthma UK Centre for Applied Research, University of Edinburgh, Edinburgh, UK.; Usher Institute, University of Edinburgh, Edinburgh, UK.; Health Data Research UK BREATHE Hub, University of Edinburgh, Edinburgh, UK., Shaheen SO; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK., Relton C; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK., Martineau AR; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK a.martineau@qmul.ac.uk.; Asthma UK Centre for Applied Research, Queen Mary University of London, London, UK.
Source: BMJ (Clinical research ed.) [BMJ] 2022 Sep 07; Vol. 378, pp. e071230. Date of Electronic Publication: 2022 Sep 07.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-1833 (Electronic) Linking ISSN: 09598138 NLM ISO Abbreviation: BMJ Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1756-1833
DOI:10.1136/bmj-2022-071230